Hosted on MSN28d
FDA grants IDE approval for NextBioMedical’s Nexsphere-F trialThe US Food and Drug Administration (FDA) has granted investigational device exemption (IDE ... The multi-centre, open-label RESORB trial will focus on providing a ‘sustainable’ and ...
MILAN, Feb. 5, 2025 /PRNewswire/ -- Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...
Its truly unique Acolyteâ„¢ Image-Guided Crossing and Re-Entry Catheter System has been granted an Investigational Device Exemption by the U.S. Food and Drug Administration (FDA), after having ...
Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results